© 2017, Xoft, a subsidiary of iCAD Inc.  All rights reserved.  Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc..

Register for a demo or event today!

Patients diagnosed with NMSC, such as basal or squamous cell carcinoma, may have concerns about scarring, wound healing or preserving functionality in anatomically challenging areas.

Discover skin eBx, a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment.

From the market leader in skin electronic brachytherapy, skin eBx provides an effective, non-surgical, convenient treatment option with excellent clinical and cosmetic results for appropriately selected patients.1 More than 10,000 NMSC patients have been successfully treated with skin eBx.

Join us at the Xoft booth to explore the unique and valuable benefits this innovative technology can offer to you, your practice and your patients.

1. A Bhatnagar, et al. High-dose Rate Electronic Brachytherapy: A Nonsurgical Treatment Alternative for Nonmelanoma Skin Cancer. The Journal of Clinical and Aesthetic Dermatology; Nov. 2016; Vol.9; No.11: 16

Squamous cell carcinoma 
Treated with 40 Gy to a 3 mm depth

Pre-Treatment

One Year